Syncona quarterly update: Net assets and portfolio value inc

Syncona Limited has issued its quarterly update, reporting an increase in net assets and a positive NAV per share return. The company's life science portfolio also saw significant growth. Read more for details. #Syncona #quarterlyupdate #lifescienceinvestment

Related Keywords

Edinburgh , City Of , United Kingdom , Rolf Soderstrom , Kate Butler , Martin Murphy , Chris Hollowood , Vectura Group , Drug Administration , Gilead Sciences Inc , University Of Edinburgh , Evaluation Committee , Syncona Investment Management Limited , Syncona Investment Management , Syncona Limited , Autolus Therapeutics , Beacon Therapeutics , Biologics License Application , Resolution Therapeutic , Freeline Therapeutics , General Meeting , Chief Financial Officer , Executive Partner , Group Finance Director , Gilead Sciences , Interim Chair , Chief Executive Officer ,